1-6 of 6
S. Pavletic, MD
Close
Sort by
Journal Articles

Recent Decrease in Acute GVHD and Increased Relapse in Children with Leukemia Receiving Unrelated Donor Bone Marrow Transplants.

Stella M. Davies, MB, BS, PhD, D. Wang, MS, T. Wang, PhD, M. Arora, MD, O. Ringden, MD, C. Anasetti, MD, S. Pavletic, MD, J. Casper, MD, M.L. MacMillan, MD, J. Sanders, MD, D. Wall, MD, N.A. Kernan, MD
Journal: Blood
Blood (2007) 110 (11): 1081.
https://doi.org/10.1182/blood.V110.11.1081.1081
Published: 2007
Journal Articles

Effect of T Cell Recovery on Overall Survival (OS) Following Pentostatin Conditioning for Nonmyeloablative Allogeneic Stem Cell Transplantation (NST).

James E. Talmadge, PhD, Ugur Coskun, PhD, Sarah Maas, MS, Orhan Turken, MD, Ziviko S. Pavletic, MD, Charles A. Kuszynski, PhD, Marcel Devetten, MD, Laura R. Schafer, MS, Lori Zobel, BS, Robert G. Bociek, MD
Journal: Blood
Blood (2007) 110 (11): 2994.
https://doi.org/10.1182/blood.V110.11.2994.2994
Published: 2007
Journal Articles

Feasibility and Reproducibility of the NIH Consensus Criteria To Evaluate Response in Chronic Graft Versus Host Disease (cGvHD).

S. Mitchell, CRNP, D. Jacobsohn, MD, K. Thormann, CRNP, E. Cowen, MD, J. Fall-Dickson, PhD, M. Turner, MD, M. Schubert, DDS, K. Baird, MD, J. Bolanos-Meade, MD, K. Boyd, DDS, L. Gerber, MD, J.P. Guadagnini, DDS, M. Higman, MD, M. Imanguli, DDS, L. Lawley, MD, L. Li, MD, O. Prachenko, MA, B. Reeve, PhD, J. Smith, MD, G. Vogelsang, MD, S. Pavletic, MD
Journal: Blood
Blood (2006) 108 (11): 5344.
https://doi.org/10.1182/blood.V108.11.5344.5344
Published: 2006
Journal Articles

Differential T Cell Suppression by Two Different Pentostatin Conditioning Protocols for Nonmyeloablative Allogeneic Stem Cell Transplantation (NST).

Ugur Coskun, MD, Robert G. Bociek, MD, Zivko S. Pavletic, MD, Charlie Kuszynski, PhD, Marcel Devetten, MD, Laura Shafer, Lori Zobel, James E. Talmadge, PhD
Journal: Blood
Blood (2006) 108 (11): 5373.
https://doi.org/10.1182/blood.V108.11.5373.5373
Published: 2006
Journal Articles

Feasibility and Reproducibility of the New NIH Consensus Criteria To Evaluate Response in Chronic GvHD - A Pilot Study.

S. Mitchell, CRNP, B. Reeve, PhD, E. Cowen, MD, J. Fall-Dickson, PhD, L. Gerber, MD, J.P. Guadagnini, DDS, M. Robinson, MD, M. Turner, MD, G. Willis, PhD, M. Schubert, DDS, J. Bolanos-Meade, MD, M. Higman, MD, D. Jacobsohn, MD, K. Thormann, CRNP, G. Vogelsang, MD, S. Pavletic, MD
Journal: Blood
Blood (2005) 106 (11): 3121.
https://doi.org/10.1182/blood.V106.11.3121.3121
Published: 2005
Journal Articles

Nonmyeloablative Allogeneic Stem Cell Transplantation (NST) for Hematologic Malignancies (HM) Using Pentostatin/Low-Dose Total Body Irradiation (TBI).

R. Gregory Bociek, MD, MSc, James E. Talmadge, PhD, James C. Lynch, PhD, Charles A. Enke, MD, Charles A. Kuszynski, PhD, Philip J. Bierman, MD, Julie M. Vose, MD, James O. Armitage, MD, Marcel P. Devetten, MD, Lori J. Maness, MD, Timothy R. McGuire, PhD, James L. Wisecarver, MD, Shantaram S. Joshi, PhD, Zivko S. Pavletic, MD
Journal: Blood
Blood (2005) 106 (11): 3671.
https://doi.org/10.1182/blood.V106.11.3671.3671
Published: 2005